FrancophonIA/ELRC3.0 huggingface dataset:
English: Schizoaffective Disorder Studies: Secondary Efficacy Parameter, Proportion of Subjects with Responder Status at LOCF End Point: Studies R076477-SCA-3001 and R076477-SCA-3002: Intent-to-Treat Analysis Set
Finnish: Skitsoaffektiiviseen häiriöön liittyvät tutkimukset: Toissijainen tehoparametri, hoitovasteen saaneiden potilaiden osuus LOCF-päätetapahtumassa: Tutkimukset R076477-SCA-3001 ja R076477-SCA-3002: Intent-to-Treatanalyysijoukko
English: The recommended dose of INVEGA for the treatment of schizophrenia in adults is 6 mg once daily, administered in the morning.
Finnish: Suositeltu INVEGA-annos aikuisille skitsofrenian hoitoon on 6 mg kerran vuorokaudessa aamuisin otettuna.
English: • restlessness
Finnish: • korvatulehdus
English: Titanium dioxide (E171) Polyethylene glycol 400 Ferric oxide (yellow) (E172) Carnauba wax
Finnish: Hypromelloosi Titaanidioksidi (E171) Polyetyleeniglykoli 400 Keltainen rautaoksidi (E172) Karnaubavaha
English: vomiting, nausea,
Finnish: • kutina, ihottuma
English: Refer to ‘Extrapyramidal symptoms' below.
Finnish: Ks. Ekstrapyramidaalioireet jäljempänä.
English: For patients with moderate to severe renal impairment (creatinine clearance  10 to < 50 mL/min), the recommended initial dose of INVEGA is 3 mg every other day, which may be increased to 3 mg once daily after clinical reassessment.
Finnish: Kohtalaista tai vaikeaa munuaisten vajaatoimintaa sairastaville (kreatiniinipuhdistuma 10 50 ml/min) suositeltu INVEGA-aloitusannos on 3 mg joka toinen päivä.
English: • swollen tongue, stomach or intestinal infection, difficulty swallowing, excessive passing of gas or wind
Finnish: • kielen turpoaminen, maha- tai suolitulehdus, nielemisvaikeudet, runsaat ilmavaivat
English: Each INVEGA 9 mg prolonged-release tablet contains 9 mg of paliperidone.
Finnish: Yksi INVEGA 9 mg:n depottabletti sisältää 9 mg paliperidonia.
English: • decrease in the type of white blood cells that help to protect you against infection, increase in eosinophils (a type of white blood cell) in your blood
Finnish: • tulehduksia vastaan suojaavien veren valkosolujen määrän väheneminen, eosinofiilien
English: Consideration should be given to the prolonged-release nature of the product when assessing treatment needs and recovery.
Finnish: Hoitotarpeen ja potilaan toipumisen arvioinnissa on otettava huomioon lääkevalmisteen pitkävaikutteinen luonne.
English: 59% of the dose was excreted unchanged into urine, indicating that paliperidone is not extensively metabolised by the liver.
Finnish: C-paliperidonin lääkeaineen välittömästi vapauttavaa lääkemuotoa annettiin suun kautta 1 mg:n kerta-annoksena, viikon kuluttua annosta virtsaan oli erittynyt muuttumattomana aineena 59 % annoksesta, mikä osoittaa, ettei paliperidoni metaboloidu tehokkaasti maksan kautta.
English: • lung congestion
Finnish: • haimatulehdus
English: Ear and labyrinth disorders vertigo, tinnitus, ear pain
Finnish: Kuulo ja tasapainoelin kiertohuimaus (vertigo), tinnitus, korvakipu
English: Cases of venous thromboembolism, including cases of pulmonary embolism and cases of deep vein thrombosis have been reported with antipsychotic drugs - Frequency unknown.
Finnish: Psykoosilääkkeiden käytön yhteydessä on raportoitu laskimoveritulppatapauksia, mukaan lukien keuhkoemboliaa ja syviä laskimotukoksia.
English: Each INVEGA 6 mg prolonged-release tablet contains 6 mg of paliperidone.
Finnish: Yksi INVEGA 6 mg:n depottabletti sisältää 6 mg paliperidonia.
English: Trilayer capsule-shaped white tablets of 11 mm in length and 5 mm in diameter printed with “PAL 3” Trilayer capsule-shaped beige tablets of 11 mm in length and 5 mm in diameter printed with “PAL 6” Trilayer capsule-shaped pink tablets of 11 mm in length and 5 mm in diameter printed with “PAL 9” Trilayer capsule-shaped yellow tablets of 11 mm in length and 5 mm in diameter printed with “PAL 12”
Finnish: Kolmesta kerroksesta koostuva kapselin muotoinen beigenvärinen tabletti, jonka pituus on 11 mm ja halkaisija 5 mm ja johon on painettu merkintä ”PAL 6”.
English: • eye infection, fungal infection of the nails, infection of the skin, skin inflammation caused by mites
Finnish: • silmätulehdus, kynsisienitulehdus, ihotulehdus, punkkien aiheuttama ihotulehdus
English: LOCF endpoint change from baseline
Finnish: LOCFpäätetapahtuman muutos lähtötilanteesta
English: Each prolonged-release tablet contains 9 mg of paliperidone.
Finnish: Yksi depottabletti sisältää 9 mg paliperidonia.
English: dizziness postural,
Finnish: PANSS-pisteiden muutos,
English: Each INVEGA 12 mg prolonged-release tablet contains 12 mg of paliperidone.
Finnish: Yksi INVEGA 12 mg:n depottabletti sisältää 12 mg paliperidonia.
English: • abdominal pain, abdominal discomfort, vomiting, nausea, constipation, diarrhoea, indigestion,
Finnish: • vatsakipu, epämukava tunne vatsassa, oksentelu, pahoinvointi, ummetus, ripuli,
English: Hypromellose Titanium dioxide (E171) Polyethylene glycol 400 Ferric oxide (red) (E172) Carnauba wax
Finnish: Hypromelloosi Titaanidioksidi (E171) Polyetyleeniglykoli 400 Keltainen rautaoksidi (E172) Punainen rautaoksidi (E172) Karnaubavaha
English: Musculoskelet al and connective tissue disorders musculoskeletal pain, back pain, arthralgia blood creatine phosphokinase increased, muscle spasms, joint stiffness, joint swelling, muscular weakness, neck pain rhabdomyolysis c, posture abnormal
Finnish: Luusto, lihakset ja sidekudos tuki- ja liikuntaelimistön kipu, selkäkipu, nivelkipu suurentunut veren kreatiinikinaasipitoisuus, lihasspasmit, nivelten jäykkyys, nivelten turpoaminen, lihasheikkous, niskakipu rabdomyolyysi c,
English: Adverse reactions that may suggest increase in prolactin levels (e.g., amenorrhoea, galactorrhoea, menstrual disturbances, gynaecomastia) were reported overall in 9.3% of subjects.
Finnish: kuukautisten puuttumista, maidonvuotoa, kuukautishäiriöitä, gynekomastiaa) raportoitiin kaikkiaan 9,3 %:lla tutkittavista.
English: disturbance in attention, dysarthria, dysgeusia, hypoaesthesia, paresthaesia neuroleptic malignant syndrome, cerebral ischaemia, unresponsive to stimuli c, loss of consciousness, depressed level of consciousness c,
Finnish: vapina tardiivi dyskinesia, kouristukset e, pyörtyminen, psykomotorinen yliaktiivisuus, asentohuimaus, keskittymiskyvyn häiriöt, dysartria, makuaistin häiriöt, hypestesia, parestesiat maligni neuroleptioireyhtymä, aivoiskemia, reagoimattomuus ärsykkeisiin c, tajunnanmenetys, alentunut tajunnantaso c,
English: Swallow whole, do not chew, divide or crush.
Finnish: Tabletit niellään kokonaisina eikä niitä saa pureskella, jakaa eikä murskata.
English: During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) can happen if you take or have taken INVEGA.
Finnish: Jos käytät INVEGA-valmistetta tai olet aiemmin käyttänyt sitä, IFIS-oireyhtymäksi kutsutun tilan kehittyminen kaihileikkauksen aikana on mahdollista.
English: INVEGA is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older.
Finnish: INVEGA on tarkoitettu aikuisille ja vähintään 15 vuoden ikäisille nuorille skitsofrenian hoitoon.
English: An approximately 3-fold increased risk of cerebrovascular adverse reactions have been seen in randomised placebo-controlled clinical trials in the dementia population with some atypical antipsychotics, including risperidone, aripiprazole, and olanzapine.
Finnish: Eräiden atyyppisten psykoosilääkkeiden, kuten risperidonin, aripipratsolin ja olantsapiinin, on satunnaistetuissa, lumekontrolloiduissa dementiapotilailla tehdyissä kliinisissä tutkimuksissa havaittu lisäävän aivoverenkiertoon liittyvien haittavaikutusten vaaran noin kolminkertaiseksi.
English: Each prolonged-release tablet contains 12 mg of paliperidone.
Finnish: Yksi depottabletti sisältää 12 mg paliperidonia.
English: Each INVEGA 3 mg prolonged-release tablet contains 3 mg of paliperidone.
Finnish: Yksi INVEGA 3 mg:n depottabletti sisältää 3 mg paliperidonia.
English: • thickening of the skin, dry skin, skin redness, skin discolouration, flaky itchy scalp or skin,
Finnish: • ihon paksuuntuminen, kuiva iho, ihon punoitus, ihon värinmuutos, ihon tai päänahan hilseilevä kutina, hilse
English: 30 prolonged-release tablets - EU/1/07/395/057 350 prolonged-release tablets - EU/1/07/395/058
Finnish: 30 depottablettia - EU/1/07/395/057 350 depottablettia - EU/1/07/395/058
English: Each prolonged-release tablet contains 6 mg of paliperidone.
Finnish: Yksi depottabletti sisältää 6 mg paliperidonia.
English: Placebo) Diff. of LS Means (SE)
Finnish: LS-menetelmän ero (keskivirhe)
English: Hepatobiliary disorders transaminases increased gamma-glutamyltran sferase increased, hepatic enzyme increased jaundice
Finnish: Maksa ja sappi suurentunut transaminaasipitoisuus suurentunut gammaglutamyyli transferaasipitoisuus, suurentunut maksaentsyymipitoisuus ikterus
English: Vascular disorders orthostatic hypotension, hypertension hypotension pulmonary embolism, venous thrombosis,
Finnish: Verisuonisto ortostaattinen hypotensio, korkea verenpaine matala verenpaine keuhkoembolia, laskimotromboosi, iskemia, punastelu
English: conjunctivitis, dry eye glaucoma, eye movement disorder c,
Finnish: Silmät näön sumeneminen valonarkuus, sidekalvotulehdus, kuivat silmät glaukooma, silmien liikehäiriö c, silmien pyöritys c,
English: 30 prolonged-release tablets - EU/1/07/395/063 350 prolonged-release tablets - EU/1/07/395/064
Finnish: 30 depottablettia - EU/1/07/395/063 350 depottablettia - EU/1/07/395/064
English: 30 prolonged-release tablets - EU/1/07/395/061 350 prolonged-release tablets - EU/1/07/395/062
Finnish: 30 depottablettia - EU/1/07/395/061 350 depottablettia - EU/1/07/395/062
English: Skin and subcutaneous tissue disorders pruritus, rash urticaria, alopecia, eczema, acne angioedema, drug eruption c, hyperkeratosis, dry skin, erythema, skin discolouration, seborrhoeic dermatitis, dandruff
Finnish: Iho ja ihonalainen kudos kutina, ihottuma urtikaria, alopesia, ekseema, akne angioedeema, lääkeaineihottuma c, hyperkeratoosi, kuiva iho, eryteema, ihon värinmuutos, seborrooinen ihotulehdus, hilse
English: constipation, diarrhoea,
Finnish: virtsatietulehdus, flunssaisuuden tunne
English: Reproductive system and breast disorders amenorrhoea erectile dysfunction,
Finnish: Sukupuolielimet ja rinnat amenorrea erektiohäiriö, ejakulaatiohäiriö, kuukautishäiriöt e,
English: Menstrual disorder includes: menstruation irregular, oligomenorrhoea
Finnish: Kuukautishäiriöt käsittävät: epäsäännölliset kuukautiset, harvoin esiintyvät kuukautiset.
English: Coated tablet core:
Finnish: Tablettipurkki:
English: Each prolonged-release tablet contains 3 mg of paliperidone.
Finnish: Yksi depottabletti sisältää 3 mg paliperidonia.
English: Change in PANSS Score 8 week, acute endpoint Mean baseline (SD) Mean change (SD) P-value (vs aripiprazole) Diff. of LS Means (SE)
Finnish: Lähtötilanteen keskiarvo (keskihajonta) Muutoksen keskiarvo (keskihajonta) P-arvo (lumelääkkeeseen verrattuna) LS-menetelmän ero (keskivirhe)
English: • infection of the chest (bronchitis), common cold symptoms, sinus infection, urinary tract infection, feeling like you have the flu
Finnish: • keuhkojen tulehdus (keuhkoputkitulehdus), flunssan oireet, nenän sivuonteloiden tulehdus,
English: 30 prolonged-release tablets - EU/1/07/395/059 350 prolonged-release tablets - EU/1/07/395/060
Finnish: 30 depottablettia - EU/1/07/395/059 350 depottablettia - EU/1/07/395/060
English: Italy
Finnish: Italia.
English: In all three studies, INVEGA was superior to placebo on PSP and CGI-S. Efficacy was also evaluated by calculation of treatment response (defined as decrease in PANSS Total Score ≥ 30%) as a secondary endpoint.
Finnish: Teho arvioitiin myös laskemalla hoitovaste (määritelty PANSS-kokonaispisteiden pienenemisenä vähintään 30 %) toissijaisena päätetapahtumana.
English: Responder, n (%) Non-responder, n (%) P value (vs Placebo) R076477-SCH-305
Finnish: LS-menetelmän ero (keskivirhe) R076477-SCH-305
English: dry mouth, toothache
Finnish: ruoansulatushäiriöt, suun kuivuminen, hammassärky
English: General disorders pyrexia, asthenia, fatigue face oedema, oedema e, chills, body temperature increased, gait abnormal, thirst, chest pain, chest discomfort, malaise hypothermia c, body temperature decreased c, drug withdrawal syndrome induration
Finnish: Yleisoireet ja antopaikassa todettavat haitat kuume, voimattomuus, väsymys kasvojen turvotus, turvotus e, vilunväristykset, kohonnut ruumiinlämpö, poikkeava kävely, jano, rintakipu, epämukava tunne rintakehässä, huonovointisuus hypotermia c,
English: 14 prolonged-release tablets - EU/1/07/395/070 28 prolonged-release tablets - EU/1/07/395/045 49 prolonged-release tablets - EU/1/07/395/046 56 prolonged-release tablets - EU/1/07/395/047 98 prolonged-release tablets - EU/1/07/395/048
Finnish: 14 depottablettia - EU/1/07/395/070 28 depottablettia - EU/1/07/395/045 49 depottablettia - EU/1/07/395/046 56 depottablettia - EU/1/07/395/047 98 depottablettia - EU/1/07/395/048
English: • ear infection
Finnish: • keuhkojen verentungos
English: confusional state, libido decreased, anorgasmia, nervousness, nightmare catatonia, somnambulism, blunted affect
Finnish: Psyykkiset häiriöt unettomuus mania, agitaatio, masennus, ahdistuneisuus unihäiriöt, sekavuustila, heikentynyt sukupuolivietti, anorgasmia, hermostuneisuus, painajaiset katatonia, unissakävely, tunnetilojen latistuminen
English: 14 prolonged-release tablets - EU/1/07/395/074 - CLEAR 28 prolonged-release tablets - EU/1/07/395/016 - CLEAR 30 prolonged-release tablets - EU/1/07/395/017 - CLEAR 49 prolonged-release tablets - EU/1/07/395/018 - CLEAR 56 prolonged-release tablets - EU/1/07/395/019 - CLEAR 98 prolonged-release tablets - EU/1/07/395/020 - CLEAR
Finnish: 14 depottablettia - EU/1/07/395/074 - KIRKAS 28 depottablettia - EU/1/07/395/016 - KIRKAS 30 depottablettia - EU/1/07/395/017 - KIRKAS 49 depottablettia - EU/1/07/395/018 - KIRKAS 56 depottablettia - EU/1/07/395/019 - KIRKAS 98 depottablettia - EU/1/07/395/020 - KIRKAS
English: 14 prolonged-release tablets - EU/1/07/395/066 - WHITE 28 prolonged-release tablets - EU/1/07/395/021 - WHITE 30 prolonged-release tablets - EU/1/07/395/022 - WHITE 49 prolonged-release tablets - EU/1/07/395/023 - WHITE 56 prolonged-release tablets - EU/1/07/395/024 - WHITE 98 prolonged-release tablets - EU/1/07/395/025 - WHITE
Finnish: 14 depottablettia - EU/1/07/395/066 - VALKOINEN 28 depottablettia - EU/1/07/395/021 - VALKOINEN 30 depottablettia - EU/1/07/395/022 - VALKOINEN 49 depottablettia - EU/1/07/395/023 - VALKOINEN 56 depottablettia - EU/1/07/395/024 - VALKOINEN 98 depottablettia - EU/1/07/395/025 - VALKOINEN
English: 14 prolonged-release tablets - EU/1/07/395/075 - WHITE 28 prolonged-release tablets - EU/1/07/395/036 - WHITE 30 prolonged-release tablets - EU/1/07/395/037 - WHITE 49 prolonged-release tablets - EU/1/07/395/038 - WHITE 56 prolonged-release tablets - EU/1/07/395/039 - WHITE 98 prolonged-release tablets - EU/1/07/395/040 - WHITE
Finnish: 14 depottablettia - EU/1/07/395/075 - VALKOINEN 28 depottablettia - EU/1/07/395/036 - VALKOINEN 30 depottablettia - EU/1/07/395/037 - VALKOINEN 49 depottablettia - EU/1/07/395/038 - VALKOINEN 56 depottablettia - EU/1/07/395/039 - VALKOINEN 98 depottablettia - EU/1/07/395/040 - VALKOINEN
English: eye rolling c, lacrimation increased, ocular hyperaemia
Finnish: lisääntynyt kyynelnesteen eritys, silmien verekkyys
English: - if you have a swallowing, stomach or intestinal disorder that reduces your ability to swallow or pass foods by normal bowel movements.
Finnish: - jos sairastat Parkinsonin tautia tai dementiaa - jos sinulla on joskus todettu sairaus, jonka oireita ovat korkea kuume ja lihasten jäykkyys
English: 14 prolonged-release tablets - EU/1/07/395/076 28 prolonged-release tablets - EU/1/07/395/053 49 prolonged-release tablets - EU/1/07/395/054 56 prolonged-release tablets - EU/1/07/395/055 98 prolonged-release tablets - EU/1/07/395/056
Finnish: 14 depottablettia - EU/1/07/395/076 28 depottablettia - EU/1/07/395/053 49 depottablettia - EU/1/07/395/054 56 depottablettia - EU/1/07/395/055 98 depottablettia - EU/1/07/395/056
English: 14 prolonged-release tablets - EU/1/07/395/071 - CLEAR 28 prolonged-release tablets - EU/1/07/395/011 - CLEAR 30 prolonged-release tablets - EU/1/07/395/012 - CLEAR 49 prolonged-release tablets - EU/1/07/395/013 - CLEAR 56 prolonged-release tablets - EU/1/07/395/014 - CLEAR 98 prolonged-release tablets - EU/1/07/395/015 - CLEAR
Finnish: 14 depottablettia - EU/1/07/395/071 - KIRKAS 28 depottablettia - EU/1/07/395/011 - KIRKAS 30 depottablettia - EU/1/07/395/012 - KIRKAS 49 depottablettia - EU/1/07/395/013 - KIRKAS 56 depottablettia - EU/1/07/395/014 - KIRKAS 98 depottablettia - EU/1/07/395/015 - KIRKAS
English: 14 prolonged-release tablets - EU/1/07/395/073 28 prolonged-release tablets - EU/1/07/395/049 49 prolonged-release tablets - EU/1/07/395/050 56 prolonged-release tablets - EU/1/07/395/051 98 prolonged-release tablets - EU/1/07/395/052
Finnish: 14 depottablettia - EU/1/07/395/073 28 depottablettia - EU/1/07/395/049 49 depottablettia - EU/1/07/395/050 56 depottablettia - EU/1/07/395/051 98 depottablettia - EU/1/07/395/052
English: 14 prolonged-release tablets - EU/1/07/395/072 - WHITE 28 prolonged-release tablets - EU/1/07/395/031 - WHITE 30 prolonged-release tablets - EU/1/07/395/032 - WHITE 49 prolonged-release tablets - EU/1/07/395/033 - WHITE 56 prolonged-release tablets - EU/1/07/395/034 - WHITE 98 prolonged-release tablets - EU/1/07/395/035 - WHITE
Finnish: 14 depottablettia - EU/1/07/395/072 - VALKOINEN 28 depottablettia - EU/1/07/395/031 - VALKOINEN 30 depottablettia - EU/1/07/395/032 - VALKOINEN 49 depottablettia - EU/1/07/395/033 - VALKOINEN 56 depottablettia - EU/1/07/395/034 - VALKOINEN 98 depottablettia - EU/1/07/395/035 - VALKOINEN
English: • feeling sleepy or less alert
Finnish: • unisuuden tunne tai vireystilan heikkeneminen
English: Butyl hydroxytoluene (E321) Ferric Oxide (Yellow) (E172) (3, 12 mg tablet only) Polyethylene Oxide 7000K Ferric Oxide (Red) (E172)
Finnish: Keltainen rautaoksidi (E172) (vain 3 mg:n ja 12 mg:n tableteissa) Polyetyleenioksidi 7000K
English: 14 prolonged-release tablets - EU/1/07/395/067 28 prolonged-release tablets - EU/1/07/395/041 49 prolonged-release tablets - EU/1/07/395/042 56 prolonged-release tablets - EU/1/07/395/043 98 prolonged-release tablets - EU/1/07/395/044
Finnish: 14 depottablettia - EU/1/07/395/067 28 depottablettia - EU/1/07/395/041 49 depottablettia - EU/1/07/395/042 56 depottablettia - EU/1/07/395/043 98 depottablettia - EU/1/07/395/044
English: Potential for gastrointestinal obstruction
Finnish: Ruoansulatuskanavan tukkeuman mahdollisuus
English: 14 prolonged-release tablets - EU/1/07/395/065 - CLEAR 28 prolonged-release tablets - EU/1/07/395/001 - CLEAR 30 prolonged-release tablets - EU/1/07/395/002 - CLEAR 49 prolonged-release tablets - EU/1/07/395/003 - CLEAR 56 prolonged-release tablets - EU/1/07/395/004 - CLEAR 98 prolonged-release tablets - EU/1/07/395/005 - CLEAR
Finnish: 14 depottablettia - EU/1/07/395/065 - KIRKAS 28 depottablettia - EU/1/07/395/001 - KIRKAS 30 depottablettia - EU/1/07/395/002 - KIRKAS 49 depottablettia - EU/1/07/395/003 - KIRKAS 56 depottablettia - EU/1/07/395/004 - KIRKAS 98 depottablettia - EU/1/07/395/005 - KIRKAS
English: • feeling thirsty
Finnish: • näön sumeneminen
English: 14 prolonged-release tablets - EU/1/07/395/068 - CLEAR 28 prolonged-release tablets - EU/1/07/395/006 - CLEAR 30 prolonged-release tablets - EU/1/07/395/007 - CLEAR 49 prolonged-release tablets - EU/1/07/395/008 - CLEAR 56 prolonged-release tablets - EU/1/07/395/009 - CLEAR 98 prolonged-release tablets - EU/1/07/395/010 - CLEAR
Finnish: 14 depottablettia - EU/1/07/395/068 - KIRKAS 28 depottablettia - EU/1/07/395/006 - KIRKAS 30 depottablettia - EU/1/07/395/007 - KIRKAS 49 depottablettia - EU/1/07/395/008 - KIRKAS 56 depottablettia - EU/1/07/395/009 - KIRKAS 98 depottablettia - EU/1/07/395/010 - KIRKAS
English: What INVEGA looks like and contents of the pack INVEGA prolonged-release tablets are capsule shaped.
Finnish: INVEGA-depottabletit ovat kapselinmuotoisia.
English: If you take more INVEGA than you should
Finnish: Jos otat enemmän INVEGA-depottabletteja kuin sinun pitäisi Ota heti yhteys lääkäriisi.
English: Butyl hydroxytoluene (E321) Polyethylene oxide 7000K Ferric oxide (red) (E172) Iron oxide (black) (E172) Hydroxyethyl cellulose Polyethylene glycol 3350 Cellulose acetate
Finnish: Butyylihydroksitolueeni (E321) Polyetyleenioksidi 7000K Punainen rautaoksidi (E172) Musta rautaoksidi (E172) Hydroksietyyliselluloosa Polyetyleeniglykoli 3350 Selluloosa-asetaatti
English: BOTTLE CARTON
Finnish: Laskimoveritulppa
English: Overcoat
Finnish: Antotapa
English: Butyl hydroxytoluene (E321) Ferric oxide (yellow) (E172) Polyethylene oxide 7000K Ferric oxide (red) (E172) Hydroxyethyl cellulose Polyethylene glycol 3350 Cellulose acetate
Finnish: Butyylihydroksitolueeni (E321) Keltainen rautaoksidi (E172) Polyetyleenioksidi 7000K Punainen rautaoksidi (E172) Hydroksietyyliselluloosa Polyetyleeniglykoli 3350 Selluloosa-asetaatti
English: Butyl hydroxytoluene (E321) Polyethylene oxide 7000K Ferric oxide (red) (E172) Ferric oxide (yellow) (E172) Hydroxyethyl cellulose Polyethylene glycol 3350 Cellulose acetate
Finnish: Butyylihydroksitolueeni (E321) Polyetyleenioksidi 7000K Punainen rautaoksidi (E172) Keltainen rautaoksidi (E172) Hydroksietyyliselluloosa Polyetyleeniglykoli 3350 Selluloosa-asetaatti
English: 14 prolonged-release tablets - EU/1/07/395/069 - WHITE 28 prolonged-release tablets - EU/1/07/395/026 - WHITE 30 prolonged-release tablets - EU/1/07/395/027 - WHITE 49 prolonged-release tablets - EU/1/07/395/028 - WHITE 56 prolonged-release tablets - EU/1/07/395/029 - WHITE
Finnish: 30 depottablettia - EU/1/07/395/027 - VALKOINEN 49 depottablettia - EU/1/07/395/028 - VALKOINEN 56 depottablettia - EU/1/07/395/029 - VALKOINEN 98 depottablettia - EU/1/07/395/030 - VALKOINEN
English: Bucureşti-Ploieşti Nr. 1A, Clădirea C1, Etaj 3, Sector 1, Bucureşti Romania
Finnish: BucureştiPloieşti Nr. 1A, Clădirea C1, Etaj 3, Sector 1, Bucureşti Romania
English: Annex I List of the names, pharmaceutical form, strength of the medicinal products, route of administration, Marketing Authorisation Holders in the Member States
Finnish: Liite I Luettelo lääkevalmisteen nimistä, lääkemuodosta, vahvuudesta, antoreitistä, myyntiluvan haltijoista jäsenvaltioissa
English: Heinzelova 62a 10 000 Zagreb Croatia
Finnish: Heinzelova 62a 10 000 Zagreb Kroatia
English: Via Vitorchiano 151 00189 Roma Italy
Finnish: Via Vitorchiano 151 00189 Roma Italia
English: B-1200 Bruxelles
Finnish: B-1200 Bruxelles Belgia
English: Bucharest Business Park Şos.
Finnish: Bucharest Business Park
English: Red Oak North South County Business Park Leopardstown
Finnish: Red Oak North South County Business Park Leopardstown Dublin 18
English: 1407 Sofia
Finnish: 1407 Sofia Bulgaria
English: C/ Josefa Valcárcel, 38 28027 Madrid Spain
Finnish: C/ Josefa Valcárcel, 38 28027 Madrid Espanja
English: Nasonex 50 mikrogrami/devā deguna aerosols, suspensija
Finnish: Nasonex 50 mikrogrami/de vā deguna aerosols, suspensija
English: Merck Sharp and Dohme Bulgaria EOOD 55, Nikola Vaptzarov blvd. EXPO 2000, East Wing, Sectors B1 & B2
Finnish: 55, Nikola Vaptzarov blvd. EXPO 2000, East Wing, Sectors B1 & B2
English: 00-867 Warszawa Poland
Finnish: Chłodna 51 00-867 Warszawa Puola
English: Edifício Vasco da Gama 2770-192 Paço de Arcos Portugal
Finnish: 2770-192 Paço de Arcos
English: Malesci Istituto Farmacobiologico S.p.A Via Lungo l'Ema 7 Bagno a Ripoli (FI) Italy
Finnish: Via Lungo l'Ema 7 Bagno a Ripoli (FI) Italia
English: Quinta da Fonte, 19
Finnish: Quinta da Fonte, 19 Edifício Vasco da Gama
English: 174 56 Alimos Greece
Finnish: Ag. Dimitriou 63 174 56 Alimos Kreikka
English: Šmartinska cesta 140 1000 Ljubljana Slovenia
Finnish: 1000 Ljubljana Slovenia
English: MSD Pharma Hungary Kft. H-1095 Budapest Lechner Ödön fasor 8.
Finnish: H-1095 Budapest Lechner Ödön fasor
English: 1120 Wien
Finnish: Am Euro Platz 2 1120 Wien Itävalta
English: 34 avenue Léonard de Vinci 92400 Courbevoie France
Finnish: 92400 Courbevoie Ranska
English: Luxembourg MSD Belgium BVBA/SPRL Clos du Lynx 5
Finnish: MSD Belgium BVBA/SPRL Clos du Lynx 5 B-1200 Bruxelles Belgia